Artal Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-300,000
| Closed | -$3.98M | – | 106 |
|
|
2023
Q3 | $3.98M | Hold |
300,000
| – | – | 0.17% | 60 |
|
|
2023
Q2 | $5.63M | Hold |
300,000
| – | – | 0.17% | 59 |
|
|
2023
Q1 | $4.33M | Hold |
300,000
| – | – | 0.26% | 64 |
|
|
2022
Q4 | $5.81M | Sell |
300,000
-100,000
| -25% | -$1.94M | 0.32% | 54 |
|
|
2022
Q3 | $13.7M | Hold |
400,000
| – | – | 0.59% | 36 |
|
|
2022
Q2 | $6.11M | Hold |
400,000
| – | – | 0.33% | 46 |
|
|
2022
Q1 | $9.13M | Hold |
400,000
| – | – | 0.38% | 51 |
|
|
2021
Q4 | $14.7M | Hold |
400,000
| – | – | 0.4% | 50 |
|
|
2021
Q3 | $18.8M | Sell |
400,000
-100,000
| -20% | -$4.7M | 0.42% | 51 |
|
|
2021
Q2 | $30.1M | Buy |
+500,000
| New | +$30.1M | 0.61% | 32 |
|